Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedes win on the EU patent but other tough questions pass to Spain

This article was originally published in Scrip

Executive Summary

When the Swedes assumed the six-month presidency of the EU Council of Ministers in July, they vowed that by the end of the year they would have made progress on a number of areas of direct relevance to the biopharmaceutical industry. To their credit, they have managed to get the member states to agree on contentious issues such as the single EU patent, but success in other areas has proved more elusive.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC005920

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel